Watertown Biotech Raises $135M One Year After $3.5B Launch

A Watertown, Massachusetts biotech company has raised $135 million, according to The Business Journals. The round lands exactly one year after the company launched with $3.5 billion in initial backing.

The figure marks a rare trajectory for a young life-sciences firm. Most biotechs spend years reaching a first nine-figure raise. This company reached its second large round inside twelve months.

What does the new money signal?

The $135 million adds to the $3.5 billion the company secured at launch. Together, the sums point to sustained investor appetite, a scarce commodity in the current biotech funding market.

The Business Journals, which first reported the raise, did not name the investors in the new round or disclose a valuation.

Why Watertown?

Watertown sits in the greater Boston biotech corridor. The area hosts a dense cluster of drug developers, contract manufacturers and research labs. A launch of $3.5 billion would rank among the largest in the region's recent history.

What comes next?

The company has not disclosed how it will deploy the $135 million. The raise, reported on the anniversary of its launch, gives the firm fresh runway as it builds on its initial capital base.